Nordic MCL2-3 Trials: Mirna-18B Overexpression Identifies a Mantle Cell Lymphoma Subgroup with Poor Survival and Improves Mipi-B Prediction of Prognosis

Nordic MCL2-3 Trials Mirna-18B Overexpression Identifies a Mantle Cell Lymphoma Subgroup with Poor Survival and Improves Mipi-B Prediction of Prognosis

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) Vol. 99; no. S1; p. 503
Main Authors: Husby, S., Ralfkiaer, U., Garde, C., Ek, S., Kolstad, A., Jerkeman, M., Laurell, A., Raty, R., Ehinger, M., Sundström, C., Karjalainen-Lindsberg, M. L., Delabie, J., Clasen-Linde, E., Brown, P. D. N., Workman, C. T., Geisler, C. H., Gronbaek, K.
Format: Journal Article
Language:English
Published: 2014
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0390-6078
1592-8721